Entasis Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Entasis Therapeutics is a small biotechnology company focused on developing treatments for serious drug-resistant bacterial infections. It operates as a subsidiary of Innoviva, Inc., following Innoviva's 2022 acquisition of Entasis Therapeutics Holdings Inc., and is based in Waltham, Massachusetts. The company maintains a pipeline of clinical and preclinical antibacterial programs, including a lead asset developed in collaboration with Zai Lab Ltd. 

Its primary customers are healthcare providers and hospitals seeking therapies for drug-resistant infections, a challenge that affects millions of patients worldwide. Positioned within the biotechnology research sector, Entasis emphasizes antimicrobial discovery and development and pursues collaborations to advance its programs.

Sign up for free to view info

Company overview Employee directory